Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Lachin, John M ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; HYPOTHESIS; LINEAR REGRESSION ANALYSIS; MATHEMATICAL VARIABLE; MULTIVARIATE ANALYSIS OF VARIANCE; OUTCOME ASSESSMENT; PROBABILITY; QUANTITATIVE ANALYSIS; RANK SUM TEST; SAMPLE SIZE; STATISTICAL MODEL; WEI LACHIN TEST; ALGORITHM; CLINICAL TRIAL (TOPIC); MULTIVARIATE ANALYSIS; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ALGORITHMS; CLINICAL TRIALS AS TOPIC; MULTIVARIATE ANALYSIS; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84908133396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108784     Document Type: Article

References (44)

1. Nathan DM, Buse JB, Kahn SE, Krause-Steinrauf H, Larkin ME, et al. (2013) Rationale and design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care 36(8): 2254-61.
2. Wei LJ, Lachin JM (1984) Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Amer Statist Assoc 79: 653-661.
3. Lachin JM (1992) Some large sample size distribution-free estimators and tests for multivariate partially incomplete observations from two populations. Stat Med 11: 1151-1170.
4. Frick H (1994) A maximin linear test and its application to Lachin's Data. Commun Statist - Theory and Methods 23: 1021-1029.
5. Frick H (1995) Comparing trials with multiple outcomes: The multivariate one-sided hypothesis with unknown covariances. Biom J 8: 909-917.
6. Lachin JM (2011) Biostatistical Methods: The Assessment of Relative Risks. Second Edition. New York: John Wiley & Sons, Inc.
7. Lachin JM, Wei LJ (1988) Estimators and tests in the analysis of multiple nonindependent 262 tables with partially missing observations. Biometrics 44: 513-528.
8. Liang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika: 73, 13-22.
9. Demidenko E (2005) Mixed Models: Theory and Applications. New York: John Wiley & Sons, Inc.
10. Wei LJ, Lin DY, Weissfeld L (1989) Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Amer Statist Assoc 84: 1065-1073.
11. Thall PF, Lachin JM (1986) Assessment of stratum-covariate interactions in Cox's proportional hazards regression model. Stat Med 5: 73-83.
12. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6: 65-70.
13. O'Brien PC (1984) Procedures for comparing samples with multiple endpoints. Biometrics 40: 1079-1087.
14. Gastwirth JL (1966) On robust procedures. J Amer Statist Assoc 61: 929-948.
15. Lachin JM (1981) Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 2: 93-113.
16. Andersen PK, Borgan O, Gill RD, Keiding N (1993) Statistical Models Based on Counting Processes. New York: Springer-Verlag.
17. Fleming TR, Harrington DP (1991) Counting Processes and Survival Analysis. New York: John Wiley & Sons, Inc.
18. Harrington DP, Fleming TR (1982) A class of rank test procedures for censored survival data. Biometrika 69: 553-566.
19. Andersen PK, Borgan O, Gill RD, Keiding N (1982) Linear nonparametric tests for comparison of counting processes, with applications to censored survival data. Int Statist Rev 50: 219-258.
20. Kalbfleisch JD, Prentice RL (1980) The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons.
21. Lakatos E (1988) Sample sizes based on the log-rank statistic in complex clinical trials. Biometrics 44: 229-241.
22. Rubenstein LV, Gail MH, Santner TJ (1981) Planning the duration of a comparative clinical trial with losses to follow-up and a period of continued observation. J Chronic Dis 34: 469-479.
23. Lachin JM, Foulkes MA (1986) Evaluation of sample size and power for analyses of survival with allowance for non-uniform patient entry, losses to follow-up, non-compliance and stratification. Biometrics 42: 507-519.
24. Freedman LS (1982) Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1: 121-129.
25. Marshall AW, Olkin I (1967) A multivariate exponential distribution, J Amer Statist Assoc 62: 30-44.
26. Hougaard P (2000) Analysis of Multivariate Survival Data. New York: Springer-Verlag.
27. Pipper CB, Ritz C, Bisgaard H (2012) A versatile method for confirmatory evaluation of the effects of a covariate in multiple models. J Royal Statist Soc Series C (Applied Statistics) 61: 315-326.
28. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
29. NCEP Adult Treatment Panel III (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-97.
30. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, et al. (2005) The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program Randomized Trial. Ann Intern Med 142: 611-619.
31. Kudô A (1963) A multivariate analogue of the one-sided test. Biometrika 50: 403-418.
32. Perlman MD (1969) One-sided testing problems in multivariate analysis. Ann Math Stat 40: 549-567.
33. Tang DI, Gnecco C, Geller NL (1989) An approximate likelihood ratio test for a normal mean vector with nonnegative components with application to clinical trials. Biometrika 76: 577-583.
34. Robertson T, Wright FT, Dykstra RL (1988) Order Restricted Statistical Inference. New York: Wiley.
35. Tamhane AC, Logan BR (2002) Accurate critical constants for the one-sided approximate likelihood ratio test of a normal mean vector when the covariance matrix is estimated. Biometrics 58: 650-656.
36. Tamhane AC, Logan BR (2003) Multiple Endpoints: An Overview and New Developments. Division of Biostatistics, Medical College of Wisconsin, Technical Report 43.
37. Follman D (1996) A simple multivariate test for one-sided alternatives. J Amer Statist Assoc 91: 854-861.
38. Bloch DA, Lai TL, Tubert-Bitter P (2001) One-sided tests in clinical trials with multiple endpoints. Biometrics 57: 1039-1047.
39. Perlman MD, Wu L (2004) A note on one-sided tests with multiple enpoints. Biometrics 60: 276-280.
40. Pocock SJ, Geller NL, Tsiatis AA (1987) The analysis of multiple endpoints in clinical trials. Biometrics 43: 487-498.
41. Läuter J (1996) Exact t and F tests for analyzing studies with multiple endpoints. Biometrics 52: 964-970.
42. Frick H (1997). A note on the bias of O'Brien's OLS test. Biometrical J. 39: 125-128.
43. Rahlfs V, Vester JC (2012) The new trend in clinical research: The multidimensional approach instead of testing individual endpoints. Pharm Med 14: 160-165 (in German, English translation available).
44. Pan Q (2013) Multiple hypotheses testing procedures in clinical trials and genomic studies. Frontiers in Public Health 1(63): 1-8. doi:10.3389/fpubh.2013.00063.